The Science of ECCO2R

Extracorporeal carbon dioxide removal (ECCO2R) provides an alternative or supplement to mechanical ventilation by removing carbon dioxide directly from the blood using techniques similar to kidney dialysis. The procedure can be performed as part of comprehensive treatment for acute respiratory failure in the intensive care unit.

Hemolung RAS

The first fully-integrated Respiratory Dialysis® system, the Hemolung RAS combines advanced technology with user-centered design to provide simple, effective, and minimally invasive extracorporeal CO2removal (ECCO2R).

Clinical Studies

The Hemolung Respiratory Assist System (RAS) received European marketing clearanceCE in 2013 as the world’s first fully integrated Respiratory Dialysis ® system. The simplicity, safety and effectiveness of the system have been demonstrated in use at more than 100 hospitals worldwide. The device is approved in 34 countries outside of the US, including Europe, Canada and Australia.
ALung Technologies is the only company currently engaged in two landmark pivotal clinical trials of ECCO2R covering the primary indications of AE-COPD and ARDS.

ECCO2R Education

Educational resources about ECCO2R are available through this website and include: education articles, case studies, white papers and seminars. Some education programs are available online via webinars and videos.

Training & Support

24/7 phone support is available in United Kingdom +44 (0)808-189-1190 and United States (Clinical Trial): 1-866-GO-ALUNG (462-5864)

The simplicity of the Hemolung Respiratory Assist system is demonstrated in our complete training video series for both CR3 and CR4 Controllers.